Wockhardt Ltd

NSE: WOCKPHARMA · BSE: 532300 · Pharmaceuticals & Biotechnology · 28 announcements

Share price: ₹2,151.00
Market cap: ₹34,952 Cr
Revenue (annual): ₹3,373 Cr
Net profit (annual): ₹213.0 Cr
P/E (TTM): 85.5×Sector 47.4×
Promoter holding: 49.08%+0.00% QoQ
FII holding: 7.23%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Board Meeting Date 5 Other Announcement 4 Annual General Meeting 4 Financial Results 3 Management Change 2 Legal & Regulatory 2 Earnings Call 2 Business Update 2 Results Update 1 Regulatory Approval 1 Fund Raise 1 Credit Rating 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

4 May 2026 15:44 IST NSE

Results Update

Wockhardt Results Update

Wockhardt Limited reported a positive Profit Before Tax (PBT) of ₹238 Crore for FY26 on total revenue of ₹3,373 Crore. Q4FY26 revenue grew 30% to ₹965 Crore, driven by biotech and antibiotic segments. The company successfully completed Phase 3 trials for five novel antibiotics and holds 859 patents.

Value: ₹3,373 Cr

Read the filing ↗